Zinc, metallothioneins, and longevity - Effect of zinc supplementation: Zincage study

Annals of the New York Academy of Sciences

Volumn 1119, Issue 1, 2007, Pages 129-146

  Mocchegiani, Eugenio ^a   Giacconi, Robertina ^a   Cipriano, Catia ^a   Costarelli, Laura ^a   Muti, Elisa ^a   Tesei, Silvia ^a   Giuli, Cinzia ^a   Papa, Roberta ^a   Marcellini, Fiorella ^a   Mariani, Erminia ^b,c   Rink, Lothar ^d   Herbein, George ^e   Varin, Audrey ^e   Fulop, Tamas ^f   Monti, Daniela ^g   Jajte, Jolanta ^h   Dedoussis, George ⁱ   Gonos, Efstathios S ^j   Trougakos, Ioannis P ^j   Malavolta, Marco ^a  

^a INRCA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^f UNIVERSITÉ DE SHERBROOKE   (Canada)

^g UNIVERSITY OF FLORENCE   (Italy)

^h MEDICAL UNIVERSITY OF LODZ   (Poland)

ⁱ HAROKOPIO UNIVERSITY   (Greece)

^j INSTITUTE OF BIOLOGY   (Greece)

more..

Author keywords

Aging; Antioxidant activity; Genetic screening; Immune response; Longevity; Metallothioneins; Zinc; Zinc supplementation

Indexed keywords

CLUSTERIN; ENDOTOXIN; INTERLEUKIN 6; ION; METALLOTHIONEIN; SUPEROXIDE DISMUTASE; THIOL GROUP; ZINC;

ADAPTIVE IMMUNITY; AGING; ANTIOXIDANT ACTIVITY; BIOLOGY; CELL DIFFERENTIATION; CONFERENCE PAPER; DIETARY INTAKE; DISEASE PREDISPOSITION; GENE EXPRESSION; GENETICS; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LONGEVITY; LYMPHOCYTE; METABOLISM; MOLECULE; NONHUMAN; NUTRITION; PHYSIOLOGY; SUPPLEMENTATION;

MUS;

EID: 36549005537     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1404.030     Document Type: Conference Paper

References (94)

1. PAOLISSO, G., M. BARBIERI, M. BONAFÈ, et al. 2000. Metabolic age modelling: the lesson from centenarians. Eur. J. Clin. Invest. 10: 888-894.
2. MEYDANI, M. 2001. Nutrition interventions in aging and age-associated disease. Ann. N. Y. Acad. Sci. 928: 226-235.
3. SHENKIN, A. 2006. Micronutrients in health and disease. Postgrad. Med. J. 82: 559-567.
4. AMES, B.N. 2006. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc. Natl. Acad. Sci. USA 103: 17589-17594.
5. KANT, A.K. 2000. Consumption of energy-dense, nutrient-poor foods by adult Americans: nutritional and health implications. The third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Clin. Nutr. 72: 929-936.
6. TUCKER, K.L. & S. BURANAPIN. 2001. Nutrition and aging in developing countries. J. Nutr. 9: 2417S-2423S.
7. FAILLA, M.L. 2003. Trace elements and host defense: recent advances and continuing challenges. J. Nutr. 133(Suppl 1): 1443S-1447S.
8. KUPPUSAMY, U.R., M. DHARMANI, M.S. KANTHIMATHI et al. 2005. Antioxidant enzyme activities of human peripheral blood mononuclear cells exposed to trace elements. Biol. Trace Elem. Res. 106: 29-40.
9. LESOURD, B. 2006. Nutritional factors and immunological ageing. Proc. Nutr. Soc. 65: 319-325.
10. LIU, J., H. ATAMNA, H KURATSUNE, et al. 2002. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann. N. Y. Acad. Sci. 959: 133-166.
11. CHERNOFF, R. 2001. Nutrition and health promotion in older adults. J. Gerontol. A. Biol. Sci. Med. Sci. 56: 47-53.
12. MARIANI, E., V. CORNACCHIOLA, M.C. POLIDORI, et al. 2006. Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zinc status: results from the Zincage Project. Biogerontology 7: 391-398.
13. ANANTHARAJU, A., A. FELLER & A. CHEDID. 2002. Aging liver. Gerontology 48: 343-353.
14. MOCCHEGIANI, E., M. MUZZIOLI, C. CIPRIANO, et al. 1998. Zinc, T-cell pathways, aging: role of metallothioneins. Mech. Ageing Dev. 106: 183-204.
15. RINK, L. & P. GABRIEL. 2000. Zinc and the immune system. Proc. Nutr. Soc. 59: 541-552.
16. RINK, L. & H. HAASE. 2007. Zinc homeostasis and immunity. Trends Immunol. 28: 1-4.
17. MOCCHEGIANI, E., M. MUZZIOLI & R. GIACCONI. 2000. Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol. Sci. 21: 205-208.
18. CIPRIANO, C., M. MALAVOLTA, L. COSTARELLI, et al. 2006. Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population. Biogerontology 7: 357-365.
19. KAGI, J.H. & A. SCHAFFER. 1998. Biochemistry of metallothionein. Biochemistry 127: 8509-8515.
20. WEST, A.K., R. STALLINGS, C.E. HILDEBRAND, et al. 1990. Human metallothionein genes: structure of the functional locus at 16q13. Genomics 8: 513-518.
21. MARET, W. & B.L. VALLEE. 1998. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc. Natl. Acad. Sci. USA 95: 3478-3482.
22. CAI, L., M. SATOH, C. TOHYAMA, et al. 1999. Metallothionein in radiation exposure: its induction and protective role. Toxicology 132: 85-98.
23. SATO, M. & M. KONDOH. 2002. Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J. Exp. Med. 196: 9-22.
24. HABEEBU, S.S., J. LIU, Y. LIU, et al. 2000. Metallothionein-null mice are more susceptible than wild-type mice to chronic CdCl(2)-induced bone injury. Toxicol. Sci. 56: 211-219.
25. SATOH, M., N. NISHIMURA, Y. KANAYAMA, et al. 1997. Enhanced renal toxicity by inorganic mercury in metallothionein-null mice. J. Pharmacol. Exp. Ther. 283: 1529-1533.
26. KONDO, Y., J.M. RUSNAK, D.G. HOYT, et al. 1997. Enhanced apoptosis in metallothionein null cells. Mol. Pharmacol. 52: 195-201.
27. KELLY, E.J., C.J. QUAIFE, G.J. FROELICK, et al. 1996. Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J. Nutr. 126: 1782-1790.
28. MOCCHEGIANI, E., L. COSTARELLI, R. et al. 2006. Nutrient-gene interaction in ageing and successful ageing. A single nutrient (zinc) and some target genes related to inflammatory/immune response. Mech. Ageing Dev. 127: 517-525.
29. ASHOK, B.T. & R. ALI. 1999: The aging paradox: free radical theory of aging. Exp. Gerontol. 34: 293-303.
30. DEGROOT, D.W., G. HAVENITH & W.L. KENNEY. 2006. Responses to mild cold stress are predicted by different individual characteristics in young and older subjects. J. Appl. Physiol. 101: 1607-1615.
31. MOCCHEGIANI, E., R. GIACCONI, C. CIPRIANO, et al. 2002. MTmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp. Gerontol. 37: 349-357.
32. WILLIAMS, P.D. & T. DAY. 2003. Antagonistic pleiotropy, mortality source interactions, and the evolutionary theory of senescence. Evolution Int. J. Org. Evolution 57: 1478-1488.
33. MOCCHEGIANI, E., M. MUZZIOLI & R. GIACCONI. 2000. Zinc, metallothioneins, immune responses, survival and ageing. Biogerontology 1: 133-143.
34. BRAVO, J. & J.K. HEATH. 2000. Receptor recognition by gp130 cytokines. EMBO J. 19: 2399-2411.
35. MORONI, F., M.L. DI PAOLO, A. RIGO, et al. 2005. Interrelationship among neutrophil efficiency, inflammation, antioxidant activity and zinc pool in very old age. Biogerontology 6: 271-281.
36. MECOCCI, P., M.C. POLIDORI, L. TROIANO, et al. 2000. Plasma antioxidants and longevity: a study on healthy centenarians. Free Radic. Biol. Med. 28: 1243-1248.
37. YANG, X., T.A. DOSER, C.X. FANG, et al. 2006. Metallothionein prolongs survival and antagonizes senescence-associated cardiomyocyte diastolic dysfunction: role of oxidative stress. FASEB J. 20: 1024-1026.
38. BARSYTE, D., D.A. LOVEJOY & G.J. LITHGOW. 2001. Longevity and heavy metal resistance in daf-2 and age-1 long-lived mutants of Caenorhabditis elegans. FASEB J. 15: 627-634.
39. FENG, W., J. CAI, W.M. PIERCE, et al. 2005. Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts. Biochem. Biophys. Res. Commun. 332: 853-858.
40. BUI, L.M., R.H. DRESSENDORFER, C.L. KEEN, et al. 1994. Zinc status and interleukin-1 beta-induced alterations in mineral metabolism in rats. Proc. Soc. Exp. Biol. Med. 206: 438-444.
41. COTO, J.A., E.M. HADDEN, M. SAURO, et al. 1992. Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C. Proc. Natl. Acad. Sci. USA 89: 7752-7756.
42. YU, C.W., J.H. CHEN & L. Y. LIN. 1997. Metal-induced metallothionein gene expression can be inactivated by protein kinase C inhibitor. FEBS Lett. 420: 69-73.
43. YIN, X., D.A. KNECHT & M.A. LYNES. 2005. Metallothionein mediates leukocyte chemotaxis. B.M.C. Immunol. 6: 21-31.
44. HUJANEN, E.S., S.T. SEPPA & K. VIRTANEN. 1995. Polymorphonuclear leukocyte chemotaxis induced by zinc, copper and nickel in vitro. Biochim. Biophys. Acta 1245: 145-152.
45. MOCCHEGIANI, E., R. GIACCONI, C. CIPRIANO, et al. 2004. The variation during the circadian cycle of liver CD1d-unrestricted NK1.1+TCRγδ- +cells lead to successful ageing. Role of metallothionein/IL-6/gp130/PARP-1 interplay in very old mice. Exp. Gerontol. 39: 775-788.
46. MOCCHEGIANI, E., R. GIACCONI, C. CIPRIANO, et al. 2002. Metallothioneins (I+II) and thyroid-thymus axis efficiency in old mice: role of corticosterone and zinc supply. Mech. Ageing Dev. 123: 675-694.
47. YOUN, J. & M.A. LYNES. 1999. Metallothionein- induced suppression of cytotoxic T lymphocyte function: an important immunoregulatory control. Toxicol. Sci. 52: 199-208.
48. EBADI, M. & S. SWANSON. 1988. The status of zinc, copper, and metallothionein in cancer patients. Prog. Clin. Biol. Res. 259: 161-175.
49. FENG, W., F.W. BENZ, J. CAI, et al. 2006. Metallothionein disulfides are present in metallothionein-overexpressing transgenic mouse heart and increase under conditions of oxidative stress. J. Biol. Chem. 281: 681-687.
50. ZANGGER, K., G. OZ, E. HASLINGER, et al. 2001. Nitric oxide selectively releases metals from the amino-terminal domain of metallothioneins: potential role at inflammatory sites. FASEB J. 15: 1303-1305.
51. MALAVOLTA, M., L. COSTARELLI, R. GIACCONI, et al. 2006. Single and three-color flowcytometry assay for intracellular zinc ion availability in human lymphocytes with Zinpyr-1 and double immunofluorescence: relationship with metallothioneins. Cytometry A 69: 1043-1053.
52. HAASE, H., S. HEBEL, G. ENGELHARDT, et al. 2006. Flow cytometric measurement of labile zinc in peripheral blood mononuclear cells. Anal. Biochem. 15: 222-230.
53. GIACCONI, R., C. CIPRIANO, E. MUTI, et al. 2005. Novel -209A/G MT2A Polymorphism in Old Patients with Type 2 Diabetes and Atherosclerosis: Relationship with Inflammation (IL-6) and Zinc. Biogerontology 6: 407-413.
54. MARET, W. 2006. Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid. Redox Signal. 8: 1419-1441.
55. COUSINS, R.J., R.K. BLANCHARD, J.B. MOORE, et al. 2003. Regulation of zinc metabolism and genomic outcomes. J. Nutr. 133(Suppl 1): 1521S-1526S.
56. VIRGILI, F., R. CANALI, E. FIGUS, et al. 1999. Intestinal damage induced by zinc deficiency is associated with enhanced CuZn superoxide dismutase activity in rats: effect of dexamethasone or thyroxine treatment. Free Radic. Biol. Med. 26: 1194-1201.
57. GUO, Z.M., H. YANG, M.L. HAMILTON, et al. 2001. Effects of age and food restriction on oxidative DNA damage and antioxidant enzyme activities in the mouse aorta. Mech. Ageing Dev. 122: 1771-1781.
58. BLANC, A., N.R. PANDEY & A.K. SRIVASTAVA. 2003: Synchronous activation of ERK 1/2, p38mapk and PKB/Akt signaling by H2O2 in vascular smooth muscle cells: potential involvement in vascular disease. Int. J. Mol. Med. 11: 229-234.
59. DROGE, W. 2002. Free radicals in the physiological control of cell function. Physiol. Rev. 82: 47-95.
60. FARACI, F.M. & S.P. DIDION. 2004. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler. Thromb. Vasc. Biol. 24: 1367-1373.
61. TROUGAKOS, I.P., G. PAWELEC, C. TZAVELAS, et al. 2006. Clusterin/Apolipoprotein J up-regulation after zinc exposure, replicative senescence or differentiation of human haematopoietic cells. Biogerontology 7: 375-382
62. MONTPIED, P., F. DE BOCK, M. BALDY-MOULINIER, et al. 1998. Alterations of metallothionein II and apolipoprotein J mRNA levels in kainate-treated rats. Neuroreport 9: 79-83.
63. MOCCHEGIANI, E., L. SANTARELLI, M. MUZZIOLI, et al. 1995. Reversibility of the thymic involution and of age-related peripheral immune dysfunctions by zinc supplementation in old mice. Int. J. Immunopharmacol. 17: 703-718.
64. TURNLUND, J.R., N. DURKIN, F. COSTA, et al. 1986. Stable isotope studies of zinc absorption and retention in young and elderly men. J. Nutr. 116: 1239-1247.
65. IBS, K.H. & L. RINK. 2003. Zinc-altered immune function. J. Nutr. 133(5 Suppl 1): 1452S-1456S.
66. DRIESSEN, C., K. HIRV, L. RINK, et al. 1994. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine Cytokine Res. 13: 15-20.
67. VON BULOW, V., L. RINK & H. HAASE. 2005. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3′,5′-cyclic monophosphate. J. Immunol. 175: 4697-4705.
68. FRAKER, P.J. & D.A. LILL-ELGHANIAN. 2004. The many roles of apoptosis in immunity as modified by aging and nutritional status. J. Nutr. Health Aging 8: 56-63.
69. OSTAN, R., S. ALBERTI, L. BUCCI, et al. 2006. Effect of zinc ions on apoptosis in PBMCs from healthy aged subjects. Biogerontology 7: 437-447.
70. BAUER, J.H. & S.L. HELFAND. 2006. New tricks of an old molecule: lifespan regulation by p53. Aging Cell 5. 437-40.
71. PROVINCIALI, M., G. DI STEFANO & S. STRONATI. 1998. Flow cytometric analysis of CD3/TCR complex, zinc, and glucocorticoid-mediated regulation of apoptosis and cell cycle distribution in thymocytes from old mice. Cytometry 32: 1-8.
72. MANN, J.J. & P.J. FRAKER. 2005. Zinc pyrithione induces apoptosis and increases expression of Bim. Apoptosis 10: 369-379.
73. IWATA, T., G.S. INCEFY, T. TANAKA, et al. 1979. Circulating thymic hormone levels in zinc deficiency. Cell. Immunol. 47: 100-105.
74. DARDENNE, M., N. BOUKAIBA, M.C. GAGNERAULT, et al. 1993. Restoration of the thymus in aging mice by in vivo zinc supplementation. Clin. Immunol. Immunopathol. 66: 127-135.
75. PIANTANELLI, L. & N. FABRIS. 1978. Hypopituitary dwarf and athymic nude mice and the study of the relationships among thymus, hormones, and aging. Birth Defects 14: 315-333.
76. ABO, T., T. KAWAMURA & H. WATANABE. 2000. Physiological responses of extrathymic T cells in the liver. Immunol. Rev. 174: 135-149.
77. DUCHATEAU, J., G. DELEPESSE, R. VRIJENS, et al. 1981. Beneficial effects of oral zinc supplementation on the immune response of old people. Am. J. Med. 70: 1001-1004.
78. SANDSTEAD, H.H., L.K. HENRIKSEN, J.L. GREGER, et al. 1982. Zinc nutriture in the elderly in relation to taste acuity, immune response, and wound healing. Am. J. Clin. Nutr. 36: 1046-1059.
79. BOGDEN, J.D., J.M. OLESKE, M.A. LAVENHAR, et al. 1990. Effects of one year of supplementation with zinc and other micronutrients on cellular immunity in the elderly. J. Am. Coll. Nutr. 9: 214-225.
80. PRASAD, A.S., J.T. FITZGERALD, J.W. HESS, et al. 1993. Zinc deficiency in elderly patients. Nutrition 9: 218-224.
81. BOUKAIBA, N., C. FLAMENT, S. ACHER, et al. 1993. A physiological amount of zinc supplementation: effects on nutritional, lipid, and thymic status in an elderly population. Am. J. Clin. Nutr. 57: 566-572.
82. CAKMAN, I., H. KIRCHNER & L. RINK. 1997. Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. J. Interferon Cytokine Res. 17: 469-472.
83. FORTES, C., F. FORESTIERE, N. AGABITI, et al. 1998. The effect of zinc and vitamin A supplementation on immune response in an older population. J. Am. Geriatr. Soc. 46: 19-26.
84. SANDSTEAD, H.H. 1995. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am. J. Clin. Nutr. 61: 621S-624S.
85. MOCCHEGIANI, E., M. MUZZIOLI, R. GIACCONI, et al. 2003. Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech. Ageing Dev. 124: 459-468.
86. FORTES, C., N. AGABITI, V. FANO, et al. 1997. Zinc supplementation and plasma lipid peroxides in an elderly population. Eur. J. Clin. Nutr. 51: 97-101.
87. NEWSOME, D.A., M SWARTZ, N.C LEONE, et al. 1988. Oral zinc in macular degeneration. Arch. Ophthalmol. 106: 192-198.
88. ROUSSEL, A.M., A. KERKENI, N. ZOUARI, et al. 2003. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J. Am. Coll. Nutr. 22: 316-321.
89. HO, E., N. QUAN, Y.H. TSAI, et al. 2001. Dietary zinc supplementation inhibits NF-kappaB activation and protects against chemically induced diabetes in CD1 mice. Exp. Biol. Med. 226: 103-111.
90. ANDREE, K.B., J. KIM, C.P. KIRSCHKE, et al. 2004. Investigation of lymphocyte gene expression for use as biomarkers for zinc status in humans. J. Nutr. 134: 1716-1723.
91. PRASAD, A.S. 2000. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J. Infect. Dis. 182: S62-S68.
92. GIACCONI, R., C. CIPRIANO, F. ALBANESE, et al. 2004. The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp. Gerontol. 39: 621-628.
93. BONAFE, M., F. OLIVIERI, L. CAVALLONE, et al. 2001. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur. J. Immunol. 31: 2357-2361.
94. NERI, S., E. MARIANI, A. MENEGHETTI, et al. 2001. Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin. Diagn. Lab. Immunol. 8: 1131-1135.